Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 12 |
NetGPI | no | yes: 0, no: 12 |
Related structures:
AlphaFold database: Q4QHQ8
Term | Name | Level | Count |
---|---|---|---|
GO:0006508 | proteolysis | 4 | 12 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 7 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009056 | catabolic process | 2 | 12 |
GO:0009057 | macromolecule catabolic process | 4 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0019538 | protein metabolic process | 3 | 12 |
GO:0019941 | modification-dependent protein catabolic process | 6 | 12 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0043632 | modification-dependent macromolecule catabolic process | 5 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0044248 | cellular catabolic process | 3 | 12 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 12 |
GO:0044265 | obsolete cellular macromolecule catabolic process | 4 | 12 |
GO:0051603 | proteolysis involved in protein catabolic process | 5 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 12 |
GO:1901575 | organic substance catabolic process | 3 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_MEL_PAP_1 | 127 | 133 | PF00089 | 0.447 |
CLV_NRD_NRD_1 | 163 | 165 | PF00675 | 0.527 |
CLV_NRD_NRD_1 | 182 | 184 | PF00675 | 0.319 |
CLV_PCSK_KEX2_1 | 182 | 184 | PF00082 | 0.588 |
CLV_PCSK_KEX2_1 | 85 | 87 | PF00082 | 0.333 |
CLV_PCSK_PC1ET2_1 | 85 | 87 | PF00082 | 0.426 |
CLV_PCSK_SKI1_1 | 164 | 168 | PF00082 | 0.486 |
CLV_PCSK_SKI1_1 | 25 | 29 | PF00082 | 0.510 |
CLV_PCSK_SKI1_1 | 69 | 73 | PF00082 | 0.546 |
CLV_PCSK_SKI1_1 | 92 | 96 | PF00082 | 0.467 |
DOC_CYCLIN_yCln2_LP_2 | 80 | 83 | PF00134 | 0.562 |
DOC_MAPK_gen_1 | 112 | 122 | PF00069 | 0.514 |
DOC_PP2B_LxvP_1 | 80 | 83 | PF13499 | 0.551 |
LIG_14-3-3_CanoR_1 | 130 | 137 | PF00244 | 0.432 |
LIG_14-3-3_CanoR_1 | 86 | 94 | PF00244 | 0.490 |
LIG_Actin_WH2_2 | 116 | 132 | PF00022 | 0.473 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.584 |
LIG_FHA_1 | 55 | 61 | PF00498 | 0.670 |
LIG_FHA_1 | 85 | 91 | PF00498 | 0.522 |
LIG_FHA_1 | 93 | 99 | PF00498 | 0.485 |
LIG_FHA_2 | 172 | 178 | PF00498 | 0.450 |
LIG_FHA_2 | 21 | 27 | PF00498 | 0.521 |
LIG_GBD_Chelix_1 | 119 | 127 | PF00786 | 0.474 |
LIG_NRBOX | 118 | 124 | PF00104 | 0.420 |
LIG_SH2_CRK | 141 | 145 | PF00017 | 0.406 |
LIG_SH2_CRK | 78 | 82 | PF00017 | 0.511 |
LIG_SH2_STAP1 | 15 | 19 | PF00017 | 0.495 |
LIG_SH2_STAP1 | 187 | 191 | PF00017 | 0.460 |
LIG_SH2_STAT5 | 118 | 121 | PF00017 | 0.419 |
LIG_SH3_3 | 14 | 20 | PF00018 | 0.432 |
LIG_SUMO_SIM_anti_2 | 70 | 76 | PF11976 | 0.475 |
LIG_SxIP_EBH_1 | 85 | 96 | PF03271 | 0.516 |
LIG_TRAF2_1 | 174 | 177 | PF00917 | 0.479 |
LIG_TRAF2_1 | 2 | 5 | PF00917 | 0.582 |
LIG_TRFH_1 | 78 | 82 | PF08558 | 0.511 |
MOD_CK1_1 | 10 | 16 | PF00069 | 0.511 |
MOD_CK1_1 | 132 | 138 | PF00069 | 0.472 |
MOD_CK2_1 | 171 | 177 | PF00069 | 0.564 |
MOD_CK2_1 | 20 | 26 | PF00069 | 0.502 |
MOD_GlcNHglycan | 12 | 15 | PF01048 | 0.567 |
MOD_GlcNHglycan | 134 | 137 | PF01048 | 0.465 |
MOD_GlcNHglycan | 48 | 52 | PF01048 | 0.768 |
MOD_N-GLC_1 | 10 | 15 | PF02516 | 0.522 |
MOD_NEK2_1 | 129 | 134 | PF00069 | 0.454 |
MOD_NEK2_1 | 7 | 12 | PF00069 | 0.488 |
MOD_PIKK_1 | 129 | 135 | PF00454 | 0.429 |
MOD_PIKK_1 | 92 | 98 | PF00454 | 0.571 |
MOD_PK_1 | 86 | 92 | PF00069 | 0.539 |
MOD_PKA_1 | 85 | 91 | PF00069 | 0.340 |
MOD_PKA_2 | 129 | 135 | PF00069 | 0.434 |
MOD_PKA_2 | 7 | 13 | PF00069 | 0.521 |
MOD_PKA_2 | 85 | 91 | PF00069 | 0.469 |
MOD_SUMO_for_1 | 60 | 63 | PF00179 | 0.588 |
TRG_DiLeu_BaEn_4 | 176 | 182 | PF01217 | 0.453 |
TRG_ENDOCYTIC_2 | 141 | 144 | PF00928 | 0.445 |
TRG_ENDOCYTIC_2 | 78 | 81 | PF00928 | 0.467 |
TRG_ER_diArg_1 | 181 | 183 | PF00400 | 0.544 |
TRG_NES_CRM1_1 | 117 | 133 | PF08389 | 0.484 |
TRG_Pf-PMV_PEXEL_1 | 92 | 96 | PF00026 | 0.523 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I1U4 | Leptomonas seymouri | 65% | 96% |
A0A0S4J983 | Bodo saltans | 31% | 77% |
A0A0S4JCU4 | Bodo saltans | 28% | 100% |
A0A1X0NIG1 | Trypanosomatidae | 38% | 100% |
A0A3S7WQT5 | Leishmania donovani | 97% | 100% |
A0A422NZK1 | Trypanosoma rangeli | 42% | 100% |
A4H5U5 | Leishmania braziliensis | 91% | 99% |
A4HU39 | Leishmania infantum | 97% | 100% |
D0A9L9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 42% | 100% |
E9AMW8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
V5BDJ1 | Trypanosoma cruzi | 40% | 100% |